Home » Stocks » MSON

Misonix, Inc. (MSON)

Stock Price: $23.02 USD -0.09 (-0.39%)
Updated Jun 24, 2021 2:23 PM EDT - Market open
Market Cap 401.75M
Revenue (ttm) 68.05M
Net Income (ttm) -18.54M
Shares Out 17.41M
EPS (ttm) -1.08
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 24
Last Price $23.02
Previous Close $23.11
Change ($) -0.09
Change (%) -0.39%
Day's Open 23.22
Day's Range 22.81 - 23.22
Day's Volume 27,243
52-Week Range 10.57 - 24.42

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Leading Medical Tech Executive Brings Extensive Industry Knowledge, Strategic Leadership and Financial Expertise to Board Leading Medical Tech Executive Brings Extensive Industry Knowledge, Strategic Le...

1 month ago - GlobeNewsWire

FARMINGDALE, N.Y., May 10, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical ...

1 month ago - GlobeNewsWire

Misonix Raises Guidance for neXus® Ultrasonic Surgical System to 200 Unit Placements by Fiscal 2021 Year-End Misonix Raises Guidance for neXus® Ultrasonic Surgical System to 200 Unit Placements by Fisca...

1 month ago - GlobeNewsWire

FARMINGDALE, N.Y., April 20, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinica...

2 months ago - GlobeNewsWire

SonicOne® Ultrasonic Wound Debridement Franchise to Provide Comprehensive Procedural Solution for Charcot Foot by Adding Complementary External Fixation Product to Reconstructive Tissue Offering SonicOn...

2 months ago - GlobeNewsWire

FARMINGDALE, N.Y., March 04, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative ...

3 months ago - GlobeNewsWire

FARMINGDALE, N.Y., March 01, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinica...

3 months ago - GlobeNewsWire

FARMINGDALE, N.Y., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical...

4 months ago - GlobeNewsWire

FARMINGDALE, N.Y., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative p...

4 months ago - GlobeNewsWire

FARMINGDALE, N.Y., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical...

5 months ago - GlobeNewsWire

FARMINGDALE, N.Y., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical...

6 months ago - GlobeNewsWire

FARMINGDALE, N.Y., Dec. 18, 2020 (GLOBE NEWSWIRE) -- 2020) – Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance ...

6 months ago - GlobeNewsWire

FARMINGDALE, N.Y., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical...

7 months ago - GlobeNewsWire

FARMINGDALE, N.Y., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical...

7 months ago - GlobeNewsWire

Misonix, Inc. (MSON) CEO Stavros Vizirgianakis on Q1 2021 Results - Earnings Call Transcript

7 months ago - Seeking Alpha

FARMINGDALE, N.Y., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative p...

7 months ago - GlobeNewsWire

FARMINGDALE, N.Y., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical...

8 months ago - GlobeNewsWire

Confirms Improving Revenue Trends, Rise in Procedure Volumes and Strong New Product Adoption Confirms Improving Revenue Trends, Rise in Procedure Volumes and Strong New Product Adoption

8 months ago - GlobeNewsWire

Expands Misonix’s Wound Tissue Regeneration Franchise and Complements Nexus SonicOne® Strategy Expands Misonix’s Wound Tissue Regeneration Franchise and Complements Nexus SonicOne® Strategy

9 months ago - GlobeNewsWire

FARMINGDALE, N.Y., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance cli...

9 months ago - GlobeNewsWire

Misonix, Inc. (MSON) CEO Stavros Vizirgianakis on Q4 2020 Results - Earnings Call Transcript

9 months ago - Seeking Alpha

Shares of Misonix (NASDAQ:MSON) were flat in after-market trading after the company reported Q4 results.

9 months ago - Benzinga

FARMINGDALE, N.Y., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerativ...

9 months ago - GlobeNewsWire

FARMINGDALE, N.Y., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clin...

10 months ago - GlobeNewsWire

FARMINGDALE, N.Y., July 30, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clin...

10 months ago - GlobeNewsWire

Full Year Revenue of Approximately $62.3 Million

11 months ago - GlobeNewsWire

Misonix, Inc. (MSON) CEO Stavros Vizirgianakis on Q3 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

With Focus on Maintaining Our Objective of Shareholder Value Creation,  Company to Prioritize Cash Preservation Through Expense Reduction,  Workforce Efficiency and Operational Synergies

1 year ago - GlobeNewsWire

No matter which strategy is employed or what types of stocks are sought after, investors want to see returns. The post 7 ‘Strong Buy’ Stocks With Over 50% Upside Potential appeared first on InvestorPl...

Other stocks mentioned: BYSI, EQT, ESTE, EVFM, PLYA, SQNS
1 year ago - InvestorPlace

Misonix, Inc. (MSON) CEO Stavros Vizirgianakis on Q2 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

FARMINGDALE, N.Y., Jan. 23, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc.  (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerati...

1 year ago - GlobeNewsWire

FARMINGDALE, N.Y., Jan. 22, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative...

1 year ago - GlobeNewsWire

Reiterates Expectation for Fiscal 2020 Full Year Pro Forma Revenue Growth of 20% Reiterates Expectation for Fiscal 2020 Full Year Pro Forma Revenue Growth of 20%

1 year ago - GlobeNewsWire

FARMINGDALE, N.Y., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc.  (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerati...

1 year ago - GlobeNewsWire

Misonix, Inc. (MSON) CEO Stavros Vizirgianakis on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

FARMINGDALE, N.Y., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance cl...

1 year ago - GlobeNewsWire

Misonix Inc (NASDAQ:MSON) files its latest 10-K with SEC for the fiscal year ended on June 30, 2019.

1 year ago - GuruFocus

Misonix, Inc. (MSON) CEO Stavros Vizirgianakis on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Misonix (NASDAQ: MSON) releases its next round of earnings this Wednesday, August 14.

1 year ago - Benzinga

Misonix, Inc. (MSON) CEO Stavros Vizirgianakis on Q3 2019 Results - Earnings Call Transcript

2 years ago - Seeking Alpha

Misonix' (MSON) CEO Stavros Vizirgianakis on Acquisition of Solsys Medical - Transcript

2 years ago - Seeking Alpha

Medical device maker Misonix, Inc. announced Thursday that it entered a definitive agreement to acquire privately held Solsys Medical, LLC in an all-stock transaction valued at about $97 million.

2 years ago - Benzinga

About MSON

Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets minimally invasive surgical ultrasonic medical devices in the United States and internationally. The company's products include BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic ... [Read more...]

Industry
Medical Devices
IPO Date
Jan 23, 1992
Stock Exchange
NASDAQ
Ticker Symbol
MSON
Full Company Profile

Financial Performance

In 2020, Misonix's revenue was $62.48 million, an increase of 60.84% compared to the previous year's $38.85 million. Losses were -$17.42 million, 135.8% more than in 2019.

Financial Statements

Analyst Forecasts

According to 3 analysts, the average rating for Misonix stock is "Strong Buy." The 12-month stock price forecast is 23.00, which is a decrease of -0.09% from the latest price.

Price Target
$23.00
(-0.09% downside)
Analyst Consensus: Strong Buy